Ignite Creation Date:
2024-05-06 @ 10:20 AM
Last Modification Date:
2024-10-26 @ 12:28 PM
Study NCT ID:
NCT03226678
Status:
COMPLETED
Last Update Posted:
2023-04-03
First Post:
2017-07-07
Brief Title:
Study to Assess the Safety Tolerability Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia wAIHA or Cold Agglutinin Disease CAD
Sponsor:
Apellis Pharmaceuticals Inc
Organization:
Apellis Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-08-31
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-12
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-07
First Submit QC Date:
July 19 2017
Study First Post Date:
2017-07-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2020-07-21
Disp First Submit QC Date:
July 21 2020
Disp First Post Date:
2020-07-23
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-03-28
Last Update Post Date:
2023-04-03
Last Update Post Date Type:
ACTUAL